Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
Susteren, Netherlands 7/13/15—Research reagent firm Nordic-MUbio has acquired the antibody and protein assets of US-based Brighter Ideas for an undisclosed amount. The acquisition includes the only source of antibodies against native Aequorea victoria green fluorescent protein (GFP). “Citations of GFP remain at a very high level since it was first described in 1994 as it […]
Hamburg, Germany 8/3/15—Life science company Eppendorf has named Thomas Bachmann as CEO (see IBO 2/15/15), effective August 1. Previously, he served as president of Bruker BioSpin (see IBO 9/30/13) and has been a member of Eppendorf’s Supervisory Board since 2013. “He has demonstrated his expertise and his strategic foresight in many ways during more than […]
Company Announcements In April, Singulex announced a partnership with the Dutch Technology Foundation to form the Biomarker Development Center. In May, MBio Diagnostics closed a $6.3 million Series B financing to further develop its portable, easy-to-use multiplex system that can detect all key analytes. Emulate announced in June research collaboration with Janssen Biotech to deploy […]
With the first half of the year behind us, let us reflect on the state of the analytical and life science instrumentation and lab products market, how it has developed thus far and what is in store for the rest of 2015. The original January forecast (see IBO 1/15/15) was published without the benefit of […]
Since its introduction in 2013, the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) 9 system for genome editing has exploded. Products for CRISPR/Cas9 range from plasmids and oligonucleotides to transgenic animals and screening services. According to Bioinformatics LLC’s report, “The Market for CRISPR/Cas9 Genome Editing Products,” published in May and based […]
Company Announcements MR Solutions appointed AXT as a distributor for Australia in February. Quanterix appointed SCRUM as its exclusive Japanese distributor for the research market in March. In April, NanoString Technologies and the University of Texas MD Anderson Cancer Center entered into a multiyear collaboration to develop “multi-omic” assays to simultaneously profile both gene and […]
As the importance of the Chinese market has grown, so have foreign companies’ R&D efforts in the country. According to a survey of 477 US companies conducted by the American Chamber of Commerce in the People’s Republic of China (AmCham) and Bain & Company in February, 46% of the companies classified as R&D Intensive Industries […]
Expanding Markets Lift Affymetrix Q1 Sales Affymetrix first quarter sales grew 6.9%, 9% excluding currency, to $88.7 million. The negative impact from currency was partially reduced by hedging gains of $2.2 million. Product sales grew 7.7% to $79.4 million. Consumables sales grew 9.4%, and Instruments sales fell 23.5% to account for 86% and 3% of […]
Expectations for industry growth showed little change compared to last fall (see IBO 10/15/14), according to IBO’s biannual Business Climate Survey. However, compared to a year ago, sentiments were more restrained. This spring, 57% of survey participants expect instrument and laboratory product–industry sales to increase moderately. Forty-three percent expect them to stay the same. However, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
